Aslan Pharmaceuticals (ASLN)
$0.6 0%
to add to portfolio
AI Score
-
Alternative
1 -
Fundamental
2 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Aslan Pharmaceuticals, AI stock picks, stock alerts and much more.
ASLN AI Stock Analysis
AI stock analysis for ASLN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aslan Pharmaceuticals (ASLN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ASLN Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aslan Pharmaceuticals (ASLN), currently trading at $0.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ASLN
-
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients.
-
Symbol
ASLN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.34 1.9% |
6 |
 |
Inovio Pharmaceuticals INO |
$4.19 4.5% |
2 |
 |
Moderna MRNA |
$43.39 3.2% |
4 |
 |
Anavex Life Sciences AVXL |
$9.03 0.1% |
4 |
 |
BridgeBio Pharma BBIO |
$27.49 4% |
5 |
ASLN Alternative Data
News Mentions
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
LinkedIn Employees
Sign up to access
Twitter Followers
Sign up to access
ASLN Financials
ASLN Key Metrics
-
Total Revenue
$0
-
Net Income
-$13.5M
-
Earnings per Share
-$0.78
-
Free cash flow
$0
-
EBITDA
-$12.5M
-
EBITDA Ratio
0
-
Total Assets
$24.6M
ASLN 2-year Revenue & Income
ASLN 2-year Free Cash Flow
ASLN Technicals
ASLN SMA
ASLN RSI
FAQ
What's the current price of Aslan Pharmaceuticals (ASLN) Stock?
The price of an Aslan Pharmaceuticals (ASLN) share is $0.6.
What's the market cap of Aslan Pharmaceuticals?
The current market cap of Aslan Pharmaceuticals is 1.7M.
Should I buy or sell ASLN?
Aslan Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Aslan Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Aslan Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Aslan Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Aslan Pharmaceuticals (ASLN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Aslan Pharmaceuticals stock right now, as the outlook appears bearish.
What are some stocks similar to Aslan Pharmaceuticals (ASLN) that investors often compare it to?
Aslan Pharmaceuticals (ASLN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Aslan Pharmaceuticals' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aslan Pharmaceuticals' stock price to be around $0.517 in 2025. Starting from the current price of $0.6, this represents a 13.8% change in price, indicating a bearish outlook for the stock.
How to buy Aslan Pharmaceuticals (ASLN) Stock?
Aslan Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aslan Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.